UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~May~~August 31, 2024

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ____________ to ____________

Commission File Number: 333-194055

AMJ Global Technology

(Exact name of registrant as specified in its charter)

Nevada

33-1230169

(State or other jurisdiction

of incorporation)

(IRS Employer

Identification Number)

2470 E Flamingo Rd., Suite A

Las Vegas, NV 89121

(Address of principal executive offices)

(213) 709-4296

(Registrant’s telephone number, including area code)

______________________________________________

(Former name or former address, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act: None.

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☐ Yes ☒ No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☒ Yes ☐ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated Filer	☒	Smaller reporting company	☒
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes ☒ No

As of ~~June~~October 2722, 2024, the Company had ~~104~~107,~~035~~782,~~523~~190 shares of common stock outstanding.

AMJ Global Technology

INDEX

		Page
PART I. FINANCIAL INFORMATION
Item 1.	Financial Statements	3
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	4
Item 3.	Quantitative and Qualitative Disclosures about Market Risks	78
Item 4.	Controls and Procedures	78
PART II. OTHER INFORMATION
Item 1.	Legal Proceedings	89
Item 1A.	Risk Factors	89
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	89
Item 3.	Defaults Upon Senior Securities	89
Item 4.	Mine Safety Disclosures	89
Item 5.	Other Information	89
Item 6.	Exhibits	910
SIGNATURES		1011

Table of Contents

PART I – FINANCIAL INFORMATION

Item 1. Financial Statements

AMJ Global Technology

Table of Contents

		Page
Condensed Balance Sheets at May 31, 2024 and November 30, 2023 (unaudited)		F-1
Condensed Balance Sheets at August 31, 2024 and November 30, 2023 (unaudited)		F-1
Condensed Statements of Operations for the three and six months ended May 31, 2024, and 2023 (unaudited)		F-2
Condensed Statements of Operations for the three and nine months ended August 31, 2024, and 2023 (unaudited)		F-2
Condensed Statements of Changes in Stockholders’ Deficit for the three and six months ended May 31, 2024, and 2023 (unaudited)		F-3
Condensed Statements of Changes in Stockholders’ Equity (Deficit) for the three and nine months ended August 31, 2024, and 2023 (unaudited)		F-3
Condensed Statements of Cash Flows for the six months ended May 31, 2024, and 2023 (unaudited)		F-4
Condensed Statements of Cash Flows for the nine months ended August 31, 2024, and 2023 (unaudited)		F-5
Notes to Unaudited Condensed Financial Statements		F-56

Table of Contents

AMJ Global Technology

Condensed Balance Sheets

(Unaudited)

	May 31,			November 30,
	August 31,			November 30,
	2024			2023
ASSETS
Current Assets
Cash	$	~~500~~229		$	-
Prepaid expenses		8,667			9,140
Accounts receivable - related party		8			-
Total Current Assets		9,167			9,140
Prepaid expenses		3,614			9,140
TOTAL ASSETS	$	9,167		$	9,140
Total Current Assets		3,851			9,140
Software and technology assets		3,371			-
Medicare contracts asset		337			-
TOTAL ASSETS	$	7,559		$	9,140
LIABILITIES AND STOCKHOLDERS' DEFICIT
Current Liabilities
Accounts payable	$	13,~~275~~393		$	750
Accrued management fees - related party		~~120~~150,000			110,000
Due to related party		-7,628			16,465
Total Current Liabilities		~~121~~161,~~275~~021			127,215
Stockholders' Deficit
Common stock, $0.001 par value, 750,000,000 shares authorized, 104,035,523 and 103,033,323 shares issued and outstanding, respectively		104,036			103,033
Common stock, $0.001 par value, 750,000,000 shares authorized, 107,782,190 and 103,033,323 shares issued and outstanding, respectively		107,782			103,033
Additional paid-in capital		~~171~~176,~~092~~817			169,469
Accumulated deficit		(~~387~~438,~~236~~061	)		(390,577	)
Total Stockholders' Deficit		(~~112~~153,~~108~~462	)		(118,075	)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$	97,~~167~~559		$	9,140

The accompanying notes are an integral part of these unaudited condensed financial statements.

F-1

Table of Contents

AMJ Global Technology

Condensed Statements of Operations

(Unaudited)

	Three Months Ended						~~Six~~Nine Months Ended
	May 31,						May 31,
	August 31,						August 31,
	2024			2023			2024			2023
Revenues	$	-		$	-		$	-		$	-
Revenues -related party	$	8		$	-		$	8		$	-
Operating Expenses
General and administrative		17,~~500~~120			-			310,~~000~~120			1,800
Professional fees		117,~~499~~949			514,~~918~~550			2937,~~673~~622			2136,~~773~~323
Management compensation		3235,~~095~~764			~~752,380~~-			6297,~~095~~859			752,380
Total operating expenses		4550,~~094~~833			~~758~~14,~~298~~550			94145,~~768~~601			~~775~~790,~~953~~503
Operating loss		(4550,~~094~~825	)		(~~758~~14,~~298~~550	)		(94145,~~768~~593	)		(~~775~~790,~~953~~503	)
Other income (expenses)
Other income
Gain on settlement of debt - related party		~~98,109~~-			-			98,109			-
Total other income		~~98,109~~-			-			98,109			-
Net Income (Loss) before income taxes		53,015			(758,298	)		3,341			(775,953	)
Net loss before income taxes		(50,825	)		(14,550	)		(47,484	)		(790,503	)
Provision for income taxes		-			-			-			-
Net Income (Loss)	$	53,015		$	(758,298	)	$	3,341		$	(775,953	)
Net Loss	$	(50,825	)	$	(14,550	)	$	(47,484	)	$	(790,503	)
Basic and diluted income (loss) per common share	$	0.00		$	(0.01	)	$	0.00		$	(0.01	)
Basic and diluted loss per common share	$	(0.00	)	$	(0.00	)	$	(0.00	)	$	(0.01	)
Basic and diluted weighted average common shares outstanding		~~103~~104,~~594~~843,~~288~~639			90,~~445~~523,~~062~~323			103,~~313~~823,~~806~~750			90,~~036~~199,~~438~~323

Prior period has been restated, see Note 1 Basis of Presentation – Restatement of Previously Issued Financial Statements.

The accompanying notes are an integral part of these unaudited condensed financial statements.

F-2

Table of Contents

AMJ Global Technology

Condensed Statement of Changes in Stockholders’ Deficit

(Unaudited)

For the Three and ~~Six~~Nine Months Ended ~~May~~August 31, 2024

					Additional					Total
	Common Stock				Paid in		Accumulated			Stockholders'
	Shares		Amount		Capital		Deficit			Deficit
Balance - November 30, 2023		103,033,323	$	103,033	$	169,469	$	(390,577	)	$	(118,075	)
Net loss for the period		-		-		-		(49,674	)		(49,674	)
Balance - February 29, 2024		103,033,323		103,033		169,469		(440,251	)		(167,749	)
Common stock issued for settlement of debt- related party		202,200		203		327		-			530
Common stock issued for compensation - related party		400,000		400		648		-			1,048
Common stock issued for services - related party		400,000		400		648		-			1,048
Net income for the period		-		-		-		53,015			53,015
Balance - May 31, 2024		104,035,523		104,036		171,092		(387,236	)		(112,108	)
Common stock issued for software and development acquisition		1,333,333		1,333		2,038		-			3,371
Common stock issued for revenue sharing agreement -related party		133,334		133		204		-			337
Common stock issued for compensation - related party		2,250,000		2,250		3,437					5,687
Common stock issued for services - related party		30,000		30		46		-			76
Net loss for the period		-		-		-		(50,825	)		(50,825	)
Balance - August 31, 2024		107,782,190		107,782		176,817		(438,061	)		(153,462	)

For the Three and Six Months Ended May 31, 2023

					Additional					Total
	Common Stock				Paid in		Accumulated			Stockholders'
	Shares		Amount		Capital		Deficit			Deficit
Balance - November 30, 2022		89,623,323	$	89,623	$	147,412	$	(253,788	)	$	(16,753	)
Net loss for the period		-		-		-		(17,655	)		(17,655	)
Balance - February 28, 2023		89,623,323		89,623		147,412		(271,443	)		(34,408	)
Common stock issued for services - related party		900,000		900		1,480		-			2,380
Net loss for the period		-		-		-		(758,298	)		(758,298	)
Balance - May 31, 2023		90,523,323	$	90,523	$	148,892	$	(1,029,741	)	$	(790,326	)

(1) Prior period has been restated, see Note 1 Basis of Presentation – Restatement of Previously Issued Financial Statements

The accompanying notes are an integral part of these unaudited condensed financial statements.

F-3

Table of Contents

For the Three and Nine Months Ended August 31, 2023

					Additional					Total
	Common Stock				Paid in		Accumulated			Stockholders'
	Shares		Amount		Capital		Deficit			Deficit

Balance - November 30, 2022		89,623,323	$	89,623	$	147,412	$	(253,788	)	$	(16,753	)

Net loss for the period		-		-		-		(17,655	)		(17,655	)
Balance - February 28, 2023		89,623,323		89,623		147,412		(271,443	)		(34,408	)

Common stock issued for services - related party		900,000		900		1,480		-			2,380
Net loss for the period		-		-		-		(758,298	)		(758,298	)
Balance - May 31, 2023		90,523,323		90,523		148,892		(1,029,741	)		(790,326	)

Net loss for the period		-		-		-		(14,550	)		(14,550	)
Balance - August 31, 2023		90,523,323	$	90,523	$	148,892	$	(1,044,291	)	$	(804,876	)

Prior period has been restated, see Note 1 Basis of Presentation – Restatement of Previously Issued Financial Statements.

The accompanying notes are an integral part of these unaudited condensed financial statements.

F-4

Table of Contents

AMJ Global Technology

Condensed Statements of Cash Flows

(Unaudited)

	Six Months Ended
	Nine Months Ended
	May 31,
	August 31,
	2024			2023
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$	3(47,~~341~~484	)	$	(~~775~~790,~~953~~503	)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock based compensation - related party		2,096			2,380
Management compensation		7,859			2,380
Gain on settlement of debt - related party		(98,109	)
Changes in operating assets and liabilities:
Prepaid expenses		473			(750	)
Accounts receivable - related party		(8	)		-
Accounts payable		525			(3,280	)
Prepaid expenses		5,526			-
Accounts payable		2,643			3,470
Accrued expenses - related party		-			750,000
Accrued management fee - related party		6090,000			-
Net cash used in operating activities		(3139,~~674~~573	)		(2734,~~603~~653	)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from related party		3239,~~174~~802			2734,~~603~~653
Net cash provided by financing activities		3239,~~174~~802			2734,~~603~~653
Net change in cash for the period		~~500~~229			-
Cash at beginning of period		-			-
Cash at end of period	$	~~500~~229		$	-
SUPPLEMENTAL CASH FLOW INFORMATION:
Cash paid for income taxes	$	-		$	-
Cash paid for interest	$	-		$	-
NON-CASH INVESTING AND FINANCING ACTIVITIES
Common stock issued for settlement of debt - related party	$	530		$	-
Common stock issued for compensation - related party	$	16,~~048~~735		$	-
Common stock issued for services - related party	$	1,~~048~~124		$	2,380
Common stock issued for software and development acquisition	$	3,371		$
Common stock issued for revenue sharing agreement - related party	$	337		$

Prior period has been restated, see Note 1 Basis of Presentation – Restatement of Previously Issued Financial Statements

The accompanying notes are an integral part of these unaudited condensed financial statements.

F-45 Table of Contents

AMJ Global Technology

Notes to Unaudited Condensed Financial Statements

~~May~~August 31, 2024

NOTE 1 – ORGANIZATION, BUSINESS AND LIQUIDITY

Business

AMJ Global Technology (the ‘Company’) was incorporated under the laws of the State of Nevada on August 16, 2013, originally incorporated as Kange Corp. Effective April 22, 2023, the Company filed with the State of Nevada a Certificate of Amendment to its Articles of Incorporation, changing the name of the Company to AMJ Global Technology. We are a start-up company developing mobile software products, starting in Estonia and Europe, which is our initial intended market. During year 2017, we began focusing on the intersection of technology and wholistic technology-based health treatments. We retained an advisor having substantial experience in the technology sector, and two former professional athletes to advise us regarding sports health issues and treatments. We intend to provide services to formulate a treatment model to meet the needs of professional athletes that suffer from PTSD and the early onset of dementia and Alzheimer’s. The Company is currently evaluating operations in the wholistic health industry, revenue sharing generated from Medicare enrollees, life and annuity insurance sales, and having 8% right and interest on software, certain additional and related assets belonged to a technology company specializing in the development of an advanced database called ElephantSqlDB® designed to leverage AI and quantum computing performance through a specialized architecture and algorithm called the Grover’s Algorithm. The ElephantSqlDB® database is unique in that is a single database that performs multiple database functions such as supporting 11 SQL dialects in addition to artificial intelligence (AI) data storage, SQL and NoSQL queries. The object of technology assets is to target and cut cloud infrastructure costs significantly while providing immutable security in-order to combat evolving threats such as ransomware attacks

On April 26, 2023, the Company entered into an assignment agreement with AMJ Global Entertainment, LLC, a Nevada limited liability company controlled by the Company’s CEO and director., pursuant to which AMJ Global Entertainment, LLC assigned to the Company 25% of the ownership rights to AMJ Global Entertainment’s intellectual property in connection with the “Blabeey” platform, including software, code and trade secrets at zero cost.

Basis of Presentation

The accompanying unaudited interim financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, the financial statements are condensed and do not include all of the information and footnotes required by GAAP for complete financial statements.

In the opinion of management, all adjustments consisting of normal recurring entries necessary for a fair statement of the periods presented for: (a) the financial position; (b) the results of operations; and (c) cash flows, have been made in order to make the financial statements presented not misleading. The results of operations for such interim periods are not necessarily indicative of operations for a full year. The accompanying unaudited interim financial statements should be read in conjunction with the financial statements and related notes included in the Company’s Annual Report on Form 10-K, for the year ended November 30, 2023, as filed with the SEC on March 12, 2024.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. The estimates and judgments will also affect the reported amounts for certain expenses during the reporting period. Actual results could differ from these good faith estimates and judgments.

Accounts Receivable

Accounts receivables are recorded in accordance with Financial Accounting Standards Board Accounting Standards Codification (ASC) 310, “Receivables.” Accounts receivables are recorded at the invoiced amount or agreement and do not bear interest. The Company does not currently have any amount recorded as an allowance for doubtful accounts. Based on the management’s estimate and based on all accounts being current, the Company has not deemed it necessary to reserve for doubtful accounts at this time.

F-6

Table of Contents

Revenue Recognition

The Company recognizes revenue from its contracts with customers in accordance with ASC 606 – Revenue from Contracts with Customers. The Company recognizes revenues when satisfying the performance obligation of the associated contract that reflects the consideration expected to be received based on the terms of the contract.

Revenue related to contracts with customers is evaluated utilizing the following steps:

	(i)	Identify the contract, or contracts, with a customer;
	(ii)	Identify the performance obligations in the contract;
	(iii)	Determine the transaction price;
	(iv)	Allocate the transaction price to the performance obligations in the contract;
	(v)	Recognize revenue when the Company satisfies a performance obligation.

The Company has one Medicare revenue sharing contract with a related party that requires 5% net revenue generated from two Medicare contracts (Note 3). The Company recognizes the monthly revenue at the beginning of August 2024 with thirty (30) days term of payment.

Equity Investment – Related Party

Equity investments with readily determinable fair values are measured at fair value. Equity investments without readily determinable fair values are measured using the equity method or measured at cost with adjustments for observable changes in price or impairments (referred to as the measurement alternative). We perform a qualitative assessment on a periodic basis and recognize an impairment if there are sufficient indicators that the fair value of the investment is less than carrying value. Changes in value are recorded in other income (expenses).

The Equity investment in AMJ Global Entertainment, LLC (“AMJ”), a related party controlled by the Company’s CEO and director, is accounted for under the equity method as the investment provides us with the ability to exercise significant influence over operating and financial policies of AMJ. On acquisition of AMJ, the investment had no value and as of ~~May~~August 31, 2024, AMJ has sustained losses. The carrying amount of this investment as of ~~May~~August 3031, 2024, is $0.

~~F-5~~Intangible ~~Table of Contents~~Assets

Intangible assets with an indefinite life are not amortized and are tested for impairment annually or more frequently if events or changes in circumstances indicate that they might be impaired. Intangible assets with finite lives are initially recorded at cost and amortized on a straight-line basis over the estimated economic useful lives of the respective assets. Acquired intangible assets from business combinations and asset acquisitions are recognized and measured at fair value at the time of acquisition. Those assets represent assets with finite lives and are further amortized on a straight-line basis over the estimated economic useful lives of the respective assets.

Net Loss Per Share of Common Stock

The Company has adopted ASC Topic 260, “Earnings per Share” which requires presentation of basic earnings per share on the face of the statements of operations for all entities with complex capital structures and requires a reconciliation of the numerator and denominator of the basic earnings per share computation. In the accompanying financial statements, basic loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the year. Diluted earnings per share is computed by dividing net income by the weighted average number of shares of common stock and potentially dilutive outstanding shares of common stock during the period to reflect the potential dilution that could occur from common shares issuable through contingent share arrangements, stock options and warrants unless the result would be antidilutive. There were no potentially dilutive shares of common stock outstanding for the ~~six~~nine months ended ~~May~~August 31, 2024, and 2023.

F-7

Table of Contents

Cash and Cash Equivalents

For purposes of balance sheet presentation and reporting of cash flows, the Company considers all unrestricted demand deposits, money market funds and highly liquid debt instruments with an original maturity of less than 90 days to be cash and cash equivalents. The Company did not have any cash equivalents at ~~May~~August 31, 2024 and November 30, 2023. The Company had cash of $~~500~~229 and $0 at ~~May~~August 31, 2024 and November 30, 2023, respectively.

Restatement of Previously Issued Financial Statements

The Company has restated amounts reported in previously issued financial statements for the periods presented in this Quarterly Report on Form 10-Q relating to errors. The restated amounts relate to share values utilized to settle transactions with related parties.

The following tables present the restatement to the line items of our previously issued financial statements to reflect the correction of errors:

Statements of Operations:

August 31, 2023	As Reported			Adjustment			As Revised
Management compensation	$	1,650,000		$	(897,620	)	$	752,380
Net loss	$	(1,688,123	)	$	897,620		$	(790,503	)

Statements of Cash Flows:

August 31, 2023	As Reported			Adjustment			As Revised
Net Loss	$	(1,688,123	)	$	897,620		$	(790,503	)
Adjustments to reconcile net loss to net cash used in operating activities:
Management compensation	$	900,000		$	(897,620	)	$	2,380

Statements of Changes in Stockholder's Deficit:

November 30, 2022	As Reported			Adjustment			As Revised
August 31, 2023	As Reported			Adjustment			As Revised
Additional paid -in-capital	$	3,255,107		$	(3,107,695	)	$	147,412
Accumulated deficit	$	(3,361,483	)	$	3,107,695		$	(253,788	)
May 31, 2023	As Reported			Adjustment			As Revised
Additional paid -in-capital	$	4,154,207		$	(4,005,315	)	$	148,892
Accumulated deficit	$	(5,~~035~~049,~~056~~606	)	$	4,005,315		$	(1,~~029~~044,~~741~~291	)

NOTE 2 – GOING CONCERN AND LIQUIDITY CONSIDERATION

Going Concern

The accompanying condensed financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company used cash in operating activities of $3139,~~674~~573 for the ~~six~~nine months ended ~~May~~August 31, 2024. The Company had an accumulated deficit of $~~387~~438,~~236~~061 at ~~May~~August 31, 2024. These factors raise substantial doubt about the ability of the Company to continue as a going concern for a reasonable period of time. The Company’s continuation as a going concern is dependent upon its ability to generate revenues and its ability to continue receiving investment capital and loans from related parties to sustain its current level of operations. The Company is in the process of securing working capital from investors for common stock, convertible notes payable, and/or strategic partnerships. No assurance can be given that the Company will be successful in these efforts.

F-6 Table of Contents

The condensed financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

~~NOTE~~F-8 3Table –of ~~RELATED PARTY TRANSACTIONS~~Contents

NOTE 3 – INTANGIBLE ASSETS

As of August 31, 2024, the Company had intangible assets as follows:

	August 31,
	2024
Software and technology assets	$	3,371
Medicare contracts asset		337
	$	3,708

On July 13, 2024, the Company entered into a Revenue Sharing agreement with a company controlled by a related party, pursuant to which the Company will receive 5% of net revenue generated from two contracts with (i) ESS in connection with Medicare enrollees, and (ii) The Agency of North Georgia in connection with Medicare, life and annuity insurance sales in exchange for 133,334 shares of common stock for a unlimited period. The Company issued 133,334 shares of common stock issued on July 10, 2024, valued at $337.

For the period of July 13, 2024 (inception) to August 31, 2024, the Company recognized $8 revenue in connection with 5% net revenue generated from two contracts.

On August 25, 2024, the Company entered into a Software Purchase and Development agreement, pursuant to which the Company acquired an 8% interest in database software and related technology assets in exchange for 1,333,333 shares of common stock. The Company issued 1,333,333 shares of common stock on August 26, 2024, valued at $3,371.

NOTE 4 – RELATED PARTY TRANSACTIONS

In support of the Company’s efforts and cash requirements, it may rely on advances from related parties until such a time that the Company can support its operations or attain adequate financing through sales of its equity or traditional debt financing. There is no formal written commitment for continued support by shareholders. Amounts represent advances or amounts paid in satisfaction of liabilities. The advances are non-interest bearing, considered temporary in nature, and have not been formalized by a promissory note.

On April 26, 2023, the Company entered into an assignment agreement with AMJ Global Entertainment, LLC, a Nevada limited liability company controlled by the Company’s CEO and director, pursuant to which AMJ Global Entertainment assigned to the Company 25% of the ownership rights to AMJ Global Entertainment’s intellectual property in connection with the “Blabeey” platform, including software, code and trade secrets at zero cost.

During the ~~six~~nine months ended ~~May~~August 31, 2024, and 2023, AMJ Global Entertainment LLC, a related party controlled by the Company’s CEO and director advanced to the Company an amount of $3139,~~674~~302 and $2734,~~603~~ 653 by paying for operating expenses on behalf of the Company, and $500 and $0 in cash, respectively.

During the ~~six~~nine months ended ~~May~~August 31, 2024, and 2023, the Company recognized management fees of $6090,000 and $0, respectively.

During the ~~six~~nine months ended ~~May~~August 31, 2024 and 2023, the Company issued ~~400~~ 430,000 and 900,000 shares of common stock to ~~four~~ advisory board members, the shares were valued and recognized compensation of $1,~~048~~124 and $2,380, respectively.

During the ~~six~~nine months ended ~~May~~August 31, 2024, the Company issued ~~400~~ 2,650,000 shares of common stock to the Company’s CEO and director and four board of directors’ members, the shares were valued and recognized compensation of $16,~~048~~735.

During the ~~six~~nine months ended ~~May~~August 31, 2024, the Company’s board of directors approved the issuance of 1100,000~~,000~~ shares of common stock for settlement of $50,000 management fees payable to the Company’s CEO and director. The shares were valued at $262, resulting in a gain of settlement on debt of $49,738.

During the ~~six~~nine months ended ~~May~~August 31, 2024, the Company’s board of directors approved the issuance of 102,200 shares of common stock for settlement of $48,639 due to AMJ Global Entertainment, LLC, a related party controlled by the Company’s CEO. The shares were valued at $268, resulting in a gain of settlement on debt of $48,371.

~~During~~F-9 ~~the~~Table ~~six~~of ~~months ended May 31,2024, the Company recognized and paid $3,000 office rent expenses to a company controlled by a related party.~~ Contents

AtDuring ~~May~~the ~~31,~~nine ~~2024~~months ~~and~~ended ~~November~~August 3031, ~~2023~~2024, the Company ~~owed~~recognized $0 and paid $164,~~465,~~500 office ~~respectively,~~rent expenses to ~~AMJ Global Entertainment LLC,~~ a ~~related~~company ~~party~~ controlled by ~~the~~a ~~Company’s~~related ~~CEO and director~~party. ~~The amount is unsecured, non-interest bearing and due on demand.~~

~~NOTE~~On 4July –13, ~~COMMON~~2024, ~~STOCK~~the Company entered into a Revenue Sharing agreement with a company controlled by a related party, pursuant to which the Company acquired 5% net revenue generated from two contracts of Medicare enrollees, life and annuity insurance, in exchange for 133,334 shares of common stock, valued at $33. For the period of July 13,2024 (inception) to August 31, 2024, the Company recognized review sharing of $8.

At August 31, 2024 and November 30, 2023, the Company owed $7,628 and $16,465, respectively, to AMJ Global Entertainment LLC, a related party controlled by the Company’s CEO and director. The amount is unsecured, non-interest bearing and due on demand.

NOTE 5 – COMMON STOCK

Common Stock

The Company has authorized common shares of 750,000,000, par value $0.001 per share. Each outstanding share of common stock entitles the holder to one vote per share on all matters submitted to a stockholder vote. All shares of common stock are non-assessable and non-cumulative, with no pre-emptive rights.

~~F-7~~During ~~Table~~the ofnine ~~Contents~~ended August 31, 2023, the Company issued following shares:

~~During~~· ~~the~~900,000 ~~year~~shares ~~ended~~of ~~November~~common ~~30,2023,~~stock to the Company’s ~~issued~~board ~~following~~advisories, ~~shares:~~valued at $2,380.

·During ~~1,400,000 shares of common stock to~~ the ~~Company’s~~nine ~~board~~months ~~advisories,~~ended itAugust ~~was valued at $3~~31,~~703.~~ ~~· 2~~2024,~~000,000~~ ~~shares of common stock as stock - based compensation to~~ the Company’s ~~CEO~~issued ~~and~~following ~~director, it was valued at $5,290. · 10,000,000~~ shares of common stock against amount owed to AMJ Global Entertainment LLC, a related party controlled by the Company’s CEO and director, it was valued at $26,448. · 10,000 shares of common stock for settlement of debt to a vendor, it was valued at $26.:

~~During~~· 2,000,000 shares of common stock to the ~~six~~Company’s ~~months~~CEO ~~ended~~and ~~May~~director, 31valued at $5,056. ~~2024~~· 650,000 shares of common stock to the Company’s board of directors, valued at $1,679. · 430,000 shares of common stock to the Company’s advisory board members, valued at $1,124. · 100,000 shares of common stock against management fees payable to the Company’s CEO and director, valued at $262. · 102,200 shares of common stock against amounts owed to AMJ Global Entertainment LLC, a related party controlled by the Company’s CEO and director, valued at $268. · 133,334 shares of common stock issued ~~following~~for Medicare contracts asset, valued at $337 · 1,333,333 shares: of common stock issued for software and development acquisition, valued at $3,371

·There ~~400~~were 107,~~000 shares of common stock to the Company’s board of directors~~782, ~~valued at $1~~190 and 103,~~048. · 400~~033,~~000~~ 323 shares of common stock toissued ~~the~~and ~~Company’s~~outstanding ~~advisory~~as ~~board~~of ~~members,~~August ~~valued at $1~~31,~~048.~~ ~~· 100~~2024,~~000~~ ~~shares of common stock against management fees payable to the Company’s CEO~~ and ~~director,~~November ~~valued at $262. · 102~~30,~~200~~ ~~shares of common stock against amounts owed to AMJ Global Entertainment LLC~~2023, ~~a related party controlled by the Company’s CEO and director, valued at $268~~respectively.

~~There~~NOTE ~~were 104,035,523~~6 ~~and 103,033,323 shares~~– ofCONCENTRATION ~~common stock issued and outstanding as of May 31, 2024, and November 30, 2023, respectively.~~

~~NOTE~~As 5of –August ~~SUBSEQUENT~~31, ~~EVENTS~~2024, and for the nine months ended August 31, 2024, customer and revenue concentrations (more than 10%) were 100% related to one revenue sharing agreement with a related party.

NOTE 7 – SUBSEQUENT EVENTS

The Company has evaluated events occurring subsequent to the balance sheet date through the date these unaudited condensed financial statements were issued and determined there are no additional events requiring disclosure.

F-810 Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Rule 175 of the Securities Act of 1933, as amended, and Rule 3b-6 of the Securities Act of 1934, as amended, that involve substantial risks and uncertainties. These forward-looking statements are not historical facts, but rather are based on current expectations, estimates and projections about our industry, our beliefs and our assumptions. Words such as “anticipate,” “expects,” “intends,” “plans,” “believes,” “seeks” and “estimates” and variations of these words and similar expressions are intended to identify forward-looking statements. These statements are not guarantees of future performance and are subject to risks, uncertainties and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements. You should not place undue reliance on these forward-looking statements, which apply only as of the date of this Form 10-Q. Investors should carefully consider all of such risks before making an investment decision with respect to the Company’s stock. The following discussion and analysis should be read in conjunction with our financial statements and summary of selected financial data for AMJ Global Technology. Such a discussion represents only the best present assessment from our Management.

Description of Company

We ~~are~~previously afocused ~~start-up~~on ~~company~~ developing mobile software. During 2017, we began focusing on the intersection of technology and wholistic technology-based health treatments. We retained an advisor having substantial experience in the technology sector, and two former professional athletes to advise us regarding sports health issues and treatments. We ~~intend~~focused toon ~~provide~~formulating ~~services to formulate~~ a treatment model to meet the needs of professional athletes that suffer from PTSD and the early onset of dementia and Alzheimer’s. ~~The Company is currently evaluating operations in the wholistic health industry.~~

On April 26, 2023, the Company entered into an assignment agreement with AMJ Global Entertainment, LLC, a Nevada limited liability company controlled by the Company’s CEO and director, pursuant to which AMJ Global Entertainment assigned to the Company 25% of the ownership rights to AMJ Global Entertainment’s intellectual property in connection with the “Blabeey” platform, including software, code and trade secrets at zero cost.

The Company is currently focusing its operations on opportunities in the wholistic health industry. In July of 2024, the Company entered into Revenue Sharing Agreement with Dark Bull Capital, Inc., a Nevada corporation (“Dark Bull”), pursuant to which the Company would issue 133,334 shares of Company common stock to Dark Bull, and the Company would receive 5% of the net revenue generated by Dark Bull from Dark Bull’s contracts with (i) ESS in connection with Medicare enrollees, and (ii) The Agency of North Georgia in connection with Medicare, life and annuity insurance sales. In August of 2024,, the Company entered into a Software Purchase and Development Agreement with Dataark Systems LLC, a Texas LLC (“Dataark”), pursuant to which the Company acquired an 8% interest in Dataark’s ElephantSqlDB® database software in consideration of the issuance of 1,333,333 shares of Company common stock to Dataark. The ElephantSqlDB® database software is designed to leverage AI and quantum computing performance through a specialized architecture and algorithm called the Grover’s Algorithm. The ElephantSqlDB® database is differentiated from its competitors in that is a single database that performs multiple database functions such as supporting 11 SQL dialects in addition to artificial intelligence (AI) data storage, SQL and NoSQL queries. The objective of this technology is to target and cut cloud infrastructure costs significantly while providing immutable security in order to combat evolving threats such as ransomware attacks.

We have had limited operations and have been issued a “going concern” opinion by our auditor on our November 30, 2023, audited financial statements based upon our reliance on related party advances and the sale of our common stock as the sole source of funds for our operations for the near future.

The following Management Discussion and Analysis should be read in conjunction with the financial statements and accompanying notes included in this Form 10-Q.

Table of Contents

Reports to Security Holders

We intend to furnish our shareholders annual reports containing financial statements audited by our independent registered public accounting firm and to make available quarterly reports containing unaudited financial statements for each of the first three quarters of each year. We voluntarily file Quarterly Reports on Form 10-Q, Annual Reports on Form 10-K and Current Reports on Form 8-K with the Securities and Exchange Commission in order to disclose relevant information regarding the Company. We may also file additional documents with the Commission if they become necessary in the course of our company’s operations.

The public may read and copy any materials that we file with the SEC at the SEC’s Public Reference Room at 100 F Street, NE, Washington, D.C. 20549. The public may obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330. The SEC maintains an Internet site that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC. The address of that site is www.sec.gov.

4 Table of Contents

Results of Operations

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the condensed financial statements and notes thereto for the period ended ~~May~~August 31, 2024, which are included herein.

Our operating results for the ~~six~~nine months ended ~~May~~August 31, 2024, and 2023 and the changes between those periods for the respective items are summarized as follows.

For the Three Months Ended ~~May~~August 31, 2024, and 2023

	Three Months Ended
	May 31,					Change
	August 31,					Change
	2024			2023		Amount
Operating loss	$	45,094		$	758,298	$	(713,204	)
Revenue -related party	$	8		$	-	$	8
Other income		(98,109	)		-		(98,109	)
Operating loss	$	50,833		$	14,550	$	36,283
Net (income) loss	$	(53,015	)	$	758,298	$	(811,313	)
Net loss	$	50,825		$	14,550	$	36,275

We ~~did~~generated ~~not~~operating ~~generate~~revenues-related ~~any~~party ~~operating~~of ~~revenues~~$8 for the three months ended ~~May~~August 31, 2024. The revenue is related to the revenue sharing agreement with Dark Bull, a company controlled by a related party, as described above and ~~2023~~pursuant to which the Company acquired 5% of Dark Bull’s net revenue generated from two contracts related to Medicare enrollees, life and annuity insurance.

The Company incurred a net ~~income~~loss of $5350,~~015~~825 during the three months ended ~~May~~August 31, 2024, compared to a net loss of $~~758~~14,~~298~~550 for the three months ended ~~May~~August 31, 2023. The ~~decrease~~increase in net loss was primarily due to aan ~~decrease~~increase in management compensation ~~and other income for a gain on settlement of debt -related party~~.

Operating expenses for the three months ended ~~May~~August 31, 2024, and 2023, were $45350,~~094~~833 and $~~758~~14,~~298~~550 respectively. For the three months ended ~~May~~August 31, 2024, and 2023, the operating expenses were primarily attributed to management compensation of $3235,~~095~~764 and $~~752~~0,~~380,~~ professional fees of $117,~~499~~949 and $514,~~918~~550, and general and administrative expenses of $17,~~500~~120 and $0, respectively.

~~Other~~For ~~income for~~ the ~~three~~Nine ~~months~~Months ~~ended~~Ended ~~May~~August 31,~~2024~~ ~~was $98~~2024,~~109~~ ~~for~~and ~~a gain on settlement of debt -related party.~~ 2023

For the Six Months Ended May 31, 2024, and 2023

	Nine Months Ended
	August 31,					Change
	2024			2023		Amount
Revenue	$	8		$	-	$	8
Operating loss	$	145,601		$	790,503	$	(644,902	)
Other income		(98,109	)		-		(98,109	)
Net loss	$	47,484		$	790,503	$	(743,019	)

	Six Months Ended
	May 31,					Change
	2024			2023		Amount
Operating loss	$	94,768		$	775,953	$	(681,185	)
Other income		(98,109	)		-		(98,109	)
Net (income) loss	$	(3,341	)	$	775,953	$	(779,294	)

We did not generate any operating revenues for the six months ended May 31, 2024, and 2023.

The Company incurred a net income of $3,341 during the six months ended May 31, 2024, compared to a net loss of $775,953 for the six months ended May 31, 2023. The decrease in net loss was primarily due to a decrease in management compensation and other income for a gain on settlement of debt -related party.

Operating expenses for the six months ended May 31, 2024, and 2023 were $94,768 and $775,953 respectively. For the six months ended May 31, 2024, and 2023, the operating expenses were primarily attributed to management compensation of $62,095 and $752,380, professional fees of $29,673 and $21,773, general and administrative expenses of $3,000 and $1,800, respectively.

Other income for the six months ended May 31,2024 was $98,109 for a gain on settlement of debt -related party.

Table of Contents

We generated operating revenues-related party of $8 for the nine months ended August 31, 2024.The revenue is related to the revenue sharing agreement described above.

The Company incurred a net loss of $47,484 during the nine months ended August 31, 2024, compared to a net loss of $790,503 for the nine months ended August 31, 2023. The decrease in net loss was primarily due to a reduction in management compensation and offset by other income for a gain on settlement of debt - related party.

Operating expenses for the nine months ended August 31, 2024, and 2023, were $145,601 and $790,503 respectively. For the nine months ended August 31, 2024, and 2023, the operating expenses were primarily attributed to management compensation of $97,859 and $752,380, professional fees of $37,622 and $36,323, and general and administrative expenses of $10,120 and $1,800, respectively.

Other income for the nine months ended August 31, 2024, was $98,109 for a gain on settlement of debt - related party.

Balance Sheet Data

	May 31,			November 30,			Change
	August 31,			November 30,			Increase
	2024			2023			~~Amount~~(Decrease)
Cash	$	~~500~~229		$	-		$	~~500~~229
Total Assets	$	97,~~167~~559		$	9,140		$	27(1,581	)
Total Liabilities	$	~~121~~161,~~275~~021		$	127,215		$	(533,~~940~~806	)
Working Capital (deficiency)	$	(~~112~~157,~~108~~170	)	$	(118,075	)	$	5(39,~~967~~095	)

Liquidity and Capital Resources

Based upon our current financial condition, we do not have sufficient cash to operate our business at the current level for the next twelve months. We intend to fund operations through debt and/or equity financing arrangements, which may be insufficient to fund expenditures or other cash requirements. We plan to seek additional financing in a private equity offering to secure funding for operations. There can be no assurance that we will be successful in raising additional funding. If we are not able to secure additional funding, the implementation of our business plan will be impaired. There can be no assurance that such additional financing will be available to us on acceptable terms or at all.

The Company is currently evaluating operations in the wholistic health industry, revenue sharing generated from Medicare enrollees, life and annuity insurance sales, and having 8% right and interest on software, certain additional and related assets belonged to a technology company specializing in the development. This operation will generate revenue and cashflow for the Company.

Working Capital

As of ~~May~~August 31, 2024, our current assets were $93,~~167~~851, and our current liabilities were $~~121~~161,~~275~~021, which resulted in working capital deficiency of $~~112~~157,~~108~~170. As of May 31, 2024, current assets were comprised of $500 in cash and $8,667 in prepaid expenses, compared to $0 in cash, $9,140 in prepaid expenses as of November 30, 2023. As of May 31, 2024, current liabilities were comprised of $1,275 in accounts payable, $120,000 in accrued management fees-related party, compared to $750 in accounts payable, $110,000 in accrued management fees - related party and $16,465 in due to related party as of November 30, 2023.

~~Our~~As ~~decrease~~of August 31, 2024, current assets were comprised of $229 in ~~working~~cash, ~~capital~~$8 ~~deficiency~~in isaccounts ~~primarily~~receivable ~~due~~- related party and $3,614 in prepaid expenses, compared to a$0 ~~decrease~~in cash and $9,140 in prepaid expenses as of November 30, 2023. As of August 31, 2024, current liabilities were comprised of $3,393 in accounts payable, $150,000 in accrued management fees - related party, and $7,628 in due to related party, ~~offset~~compared byto an$750 ~~increase~~in accounts payable, $110,000 in accrued management fees –- related party., and $16,465 in amounts due to a related party as of November 30, 2023.

Our increase in working capital deficiency is primarily due to an increase in amounts due to a related party and a decrease in cash and prepaid expenses.

Table of Contents

Cash Flow Data

	Six Months Ended
	Nine Months Ended
	May 31,
	August 31,
	2024			2023
Cash used in operating activities	$	(3139,~~674~~573	)	$	(2734,~~603~~653	)
Cash provided by financing activities		3239,~~174~~802			2734,~~603~~653
Net change in cash for the period	$	~~500~~229		$	-

Cash Flows from Operating Activities

We did not generate positive cash flows from operating activities for the ~~six~~nine months ended ~~May~~August 31, 2024, and 2023.

6For ~~Table~~the nine months ended August 31, 2024, net cash flows used in operating activities was $39,573, consisting of ~~Contents~~a net loss of $3,917,721, reduced by management compensation of $3,878,096, accrued management fees - related party of $90,000, changes in operating assets and liabilities of $8,161, and increased by a gain on settlement of debt – related party of $98,109.

For the ~~six~~nine months ended ~~May~~August 31, ~~2024~~2023, net cash flows used in operating activities was $3134,~~674~~653 consisting of a net ~~income~~loss of $3790,~~341~~503, ~~increased~~reduced by ~~stock-based~~management compensation ~~– related party~~ of $2,~~096~~380, accrued ~~management~~expenses ~~fees~~ - related party of $60750,000, ~~changes~~and a change in operating assets and liabilities of $~~998 and reduced by a gain on settlement of debt – related party of $98~~3,~~109~~470.

For the six months ended May 31, 2023, net cash flows used in operating activities was $27,603 consisting of a net loss of $775,953, reduced by stock-based compensation – related party of $2,380, accrued expenses -related party of $750,000 and increased by a change in operating assets and liabilities of $4,030.

Cash Flows from Investing Activities

For the ~~six~~nine months ended ~~May~~August 31, 2024, and 2023, no cashflows were used in or provided by investing activities.

Cash Flows from Financing Activities

We fund our operations with cash received from advances from officers and related parties and issuances of equity.

During the ~~six~~nine months ended ~~May~~August 31, 2024, and 2023, AMJ Global Entertainment LLC, a related party controlled by the Company’s CEO and director, advanced to the Company $3239,~~174~~802 and $2734,~~603~~653, respectively, by paying for operating expenses on behalf of the Company.

Off-Balance Sheet Arrangements

The Company does not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on the Company’s financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors.

Critical Accounting Policies

Use of Estimates. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Concentration

As of August 31, 2024, and for the nine months ended August 31, 2024, customer and revenue concentrations (more than 10%) were 100% related to one revenue sharing agreement with a related party.

Table of Contents

Off-Balance Sheet Arrangements

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

As the Company is a “smaller reporting company,” this item is inapplicable.

ITEM 4. CONTROLS AND PROCEDURES.

Disclosure Controls and Procedures

The Securities and Exchange Commission defines the term “disclosure controls and procedures” to mean the company’s controls and other procedures of an issuer that are designed to ensure that information required to be disclosed in the reports that it files or submits under the Securities Exchange Act of 1934 (the “Exchange Act”) is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Securities Exchange Act of 1934 is accumulated and communicated to the issuer’s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. The Company maintains such a simple system of controls and procedures in an effort to ensure that all information which it is required to disclose in the reports it files under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified under the SEC’s rules and forms and that information required to be disclosed is accumulated and communicated to principal executive and principal financial officers to allow timely decisions regarding disclosure.

As of the end of the period covered by this report, we carried out an evaluation, under the supervision and with the participation of our chief executive officer and chief financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures. Based on this evaluation, our chief executive officer and chief financial officer concluded that our disclosure controls and procedures were not effective to provide reasonable assurance of achieving the objectives of timely alerting them to material information required to be included in our periodic SEC reports and of ensuring that such information is recorded, processed, summarized and reported with the time periods specified. Our chief executive officer and chief financial officer also concluded that our disclosure controls and procedures were not effective as of the end of the period covered by this report to provide reasonable assurance of the achievement of these objectives.

Changes in Internal Control over Financial Reporting

There were no changes in the Company’s internal control over financial reporting identified in connection with the evaluation required by paragraph (d) of Rule 13a-15 or 15d-15 of the Exchange Act that occurred during the quarter ended ~~May~~August 31, 2024, that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

78 Table of Contents

PART II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS.

The Company is not a party to any significant pending legal proceedings other than as disclosed below, and no other such proceedings are known to be contemplated. No director, officer or affiliate of the Company, and no owner of record or beneficial owner of more than 5.0% of the securities of the Company, or any associate of any such director, officer or security holder is a party adverse to the Company or has a material interest adverse to the Company in reference to pending litigation.

ITEM 1A. RISK FACTORS.

Not applicable.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

None.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

During the period ended May 31, 2024, the Company issued 1,002,200 shares of common stock for settlement of debts, compensation-related party, and services-related party, as follows:

On ~~March~~July 2810, 2024, the Company issued ~~100~~133,~~000~~334 shares of common stock to ~~Robert~~Dark ~~Stutman~~Bull, ina ~~consideration~~company ofcontrolled ~~his~~by ~~appointment~~a asrelated aparty, ~~member~~pursuant ofto the ~~Board~~revenue ofsharing ~~Directors~~agreement ofdescribed ~~the Company~~above, valued at $~~262~~337.

On ~~March~~August 286, 2024, the Company issued ~~100~~2,000,000 shares of common stock to ~~Adrian~~the ~~Neilan~~Company’s inCEO, ~~consideration~~Dr. ofArther ~~his~~Malone, ~~appointment~~Jr., as ~~a member of the Board of Directors of the Company~~compensation, valued at $~~262~~5,056.

On ~~March~~August 286, 2024, the Company issued 100,000 shares of common stock to ~~Vern~~Robert ~~Barkdull~~Stutman, ~~in consideration of his appointment as~~ a member of the Company’s Board of Directors, ofas ~~the Company~~compensation, valued at $~~262~~253.

On ~~March~~August 286, 2024, the Company issued ~~100~~50,000 shares of common stock to Jesse Anglen, ~~in consideration of his appointment as~~ a member of the Company’s Board of Directors, ofas ~~the Company~~compensation, valued at $~~262~~126.

On ~~March~~August 286, 2024, the Company issued ~~100~~50,000 shares of common stock to ~~Wendell~~Adrian ~~Johnson~~Neilan, ~~in consideration of his appointment as~~ a member of the Company’s Board of ~~Advisors~~Directors, as compensation, valued at $~~262~~126.

On ~~March~~August 286, 2024, the Company issued ~~100~~50,000 shares of common stock to ~~Roman~~Jesse ~~Phifer~~Vern inBarkdull, ~~consideration of his appointment as~~ a member of the Company’s Board of ~~Advisors~~Directors, as compensation, valued at $~~262~~126.

On ~~April~~August 36, 2024, the Company issued ~~100~~30,000 shares of common stock to ~~Jerry~~Alan ~~Doby~~Klitenic in consideration of his appointment as a member of the Company’s Board of Advisors, valued at $~~262~~76.

On ~~April~~August 326, 2024, the Company issued ~~100~~1,~~000~~333,333 shares of common stock to ~~Paul~~Dataark ~~Ring~~for inthe ~~consideration~~acquisition of ~~his~~8% ~~appointment~~of asthe adatabase ~~member~~software ofand ~~the~~related ~~Company’s~~technology ~~Board~~assets ofdescribed ~~Advisors~~above, valued at $~~262~~3,371.

On May 28, 2024, the Company issued 102,200 shares of common stock to AMJ Global Entertainment LLC (which is controlled by the Company’s CEO, Dr. Arthur Malone, Jr.) in settlement of $48,639 in debt.

On May 28, 2024, the Company issued 100,000 shares of common stock to the Company’s CEO, Dr. Arther Malone, Jr., as partial settlement of $50,000 in salary payable to Dr. Malone.

The above-described shares were issued pursuant to the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended, and Rule 506(b) promulgated thereunder, as there was no general solicitation, the shareholders were accredited and/or financially sophisticated, and the transactions did not involve a public offering.

ITEM 4. MINE SAFETY DISCLOSURES.

None.

ITEM 5. OTHER INFORMATION.

None.

89 Table of Contents

ITEM 6. EXHIBITS.

Exhibit		Description
3.1		Articles of Incorporation (incorporated by reference to our Registration Statement on Form S-1, filed on February 21, 2014)
3.2		Bylaws (incorporated by reference to our Registration Statement on Form S-1, filed on February 21, 2014)
10.1		Assignment of Rights Agreement between the Company and AMJ Global (incorporated by reference to our Current Report on Form 8-K filed on November 12, 2015)
10.2		Board Member Agreement, by and between the Company and Robert Stutman, dated March 26, 2024 (incorporated by reference to Exhibit 10.1 to our Current Report on Form 8-K filed on April 1, 2024)
10.3		Board Member Agreement, by and between the Company and Adrian Neilan, dated March 26, 2024 (incorporated by reference to Exhibit 10.2 to our Current Report on Form 8-K filed on April 1, 2024)
10.4		Board Member Agreement, by and between the Company and Jesse Anglen, dated March 26, 2024 (incorporated by reference to Exhibit 10.3 to our Current Report on Form 8-K filed on April 1, 2024)
10.5		Board Member Agreement, by and between the Company and Vern Barkdull, dated March 26, 2024 (incorporated by reference to Exhibit 10.4 to our Current Report on Form 8-K filed on April 1, 2024)
10.6		Revenue Sharing Agreement, by and between the Company and Dark Bull, dated July 13, 2024 (incorporated by reference to Exhibit 10.1 to our Current Report on Form 8-K filed on July 18, 2024)
10.7		Software Purchase and Development Agreement between AMJ Global Technology and Dataark Systems LLC, dated August 25, 2024 (incorporated by reference to Exhibit 10.1 to our Current Report on Form 8-K filed on August 27, 2024)
31.1/31.2*		Certification of Chief Executive Officer and Chief Executive Financial Officer required by Rule 13a-14(1) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1/32.2*		Certification of Chief Executive Officer and Chief Executive Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and Section 1350 of 18 U.S.C. 63
101*		Inline XBRL Document Set for the condensed financial statements and accompanying notes in Part I, Item 1, “Financial Statements” of this Quarterly Report on Form 10-Q.
104*		Inline XBRL for the cover page of this Quarterly Report on Form 10-Q, included in the Exhibit 101 Inline XBRL Document Set.

____________

* Filed herewith.

910 Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	AMJ Global Technology
Date: July 3, 2024	By:	/s/ Dr. Arthur Malone, Jr.
Date: October 23, 2024	By:	/s/ Dr. Arthur Malone, Jr.
		Dr. Arthur Malone, Jr.
		Chief Executive Officer,Chief Financial Officer and Director

1011

Filing Compare · AMJ Global Technology